Please Wait.....
Report
Global Enteral Feeding Formulas - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 153 Pages I Mordor Intelligence
Global Enteral Feeding Formulas Market Analysis
The enteral nutrition market size stands at USD 9.22 billion in 2025 and is forecast to reach USD 11.87 billion by 2030, reflecting a 5.18% CAGR over the period. Momentum arises from demographic aging, rising chronic disease incidence, and accumulating clinical evidence that tube feeding shortens hospital stays and lowers infection risk versus parenteral options. Technology-enabled pumps, clean-label formulas, and AI-driven nutrient titration broaden clinical acceptance, while capacity expansions by Abbott and Danone underscore sustained demand. Although supply-chain fragilities in amino acids persist, strategic sourcing initiatives and near-shoring temper price volatility. The enteral nutrition market increasingly functions as a core component of chronic-care infrastructure rather than a niche adjunct therapy.
Global Enteral Feeding Formulas Market Trends and Insights
Aging Population & Surge in Chronic Diseases
One in six people globally will be over 65 by 2050, driving sustained demand for specialized tube-feeding solutions. Abbott's Ensure surpassed USD 3 billion sales in 2024, illustrating how older adults prioritize nutritional maintenance. Intensifying diabetes, cardiovascular, and gastrointestinal conditions further enlarge the enteral nutrition market as oral intake declines. Randomized studies show early enteral nutrition lowers mortality and shortens hospital stays, prompting payers to treat feeding tubes as preventive care. Health-system protocols now mandate enteral initiation within 48 hours of ICU admission, cementing its role as first-line therapy rather than secondary support.
Rapid Uptake of Home-Enteral Pumps & Accessories
Home health outlays are rising 6-8% annually, building a supportive payment environment for at-home tube feeding. Kangaroo Connect pumps offer 24-hour batteries and cloud telemetry that caregivers manage via smartphones. U.S. Medicare eased paperwork for enteral claims in 2025, accelerating discharges to community settings. Families value quality-of-life gains as portable pumps reduce tethering to hospital beds. These dynamics push the enteral nutrition market toward decentralized, patient-centric delivery models.
Other drivers and restraints analyzed in the detailed report include:
Shift from Parenteral to Enteral Nutrition in Acute-Care Settings / Clean-Label Real-Food Formulas Boosting Patient Adherence / GI-Related Complications & Aspiration Risk Perceptions / Fragmented Reimbursement for Disease-Specific Formulas /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Standard polymeric blends retained leadership, accounting for 54.31% of the enteral nutrition market share in 2024, largely due to broad clinical familiarity and lower unit costs. Emerging blenderized real-food offerings captured caregiver interest and are forecast for 6.15% CAGR, propelled by plant-based branding and demonstrated GI benefits.
In response, incumbents incorporate organic pea protein and non-GMO oils into legacy lines, while high-protein and peptide-based variants defend niches where malabsorption or wound healing require elevated amino acid density. Elemental formulas remain essential for severe GI compromise yet face palatability and cost barriers, limiting widespread diffusion. Disease-specific products addressing diabetes or renal impairment align with precision-nutrition trends, signaling future premiumization of the enteral nutrition market.
Isocaloric (? 1 kcal/ml) products secured 45.89% share of the enteral nutrition market size in 2024 because they satisfy most standard feeding prescriptions. Hypercaloric (1.2-1.5 kcal/ml) lines will expand 5.89% CAGR, driven by fluid-restricted cardiac and renal patients requiring compact nutrient delivery.
Formulation advances allow higher caloric density without excessive viscosity, improving pump compatibility and patient comfort. Very-high-calorie products (? 2 kcal/ml) answer severe malnutrition but remain niche due to tolerance issues, whereas low-energy blends meet pediatric and bariatric protocols. Intensifying homecare favors concentrated formats that minimize bag changes and enhance mobility, reinforcing hypercaloric momentum within the enteral nutrition market.
The Enteral Nutrition Report is Segmented by Product Type (Standard Polymeric, High-Protein Polymeric, Peptide-Based, Elemental, Disease-Specific, and More), Caloric Density (Low Energy, Isocaloric, and More), End-User (Hospitals, Long-Term Care, and More), Age Group (Neonates, Pediatrics, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).
Geography Analysis
North America contributed 42.23% of global revenue in 2024 due to sophisticated reimbursement systems, high ICU penetration of tube feeding, and rapid uptake of AI-driven pumps. U.S. Medicare's simplified billing codes and Canada's single-payer coverage sustain volume, while Mexico's growing middle class begins demanding premium formulas. Regional manufacturing, exemplified by Abbott's USD 92 million Gujarat facility serving U.S. export as well as Indian domestic demand, bolsters supply resilience.
Europe shows steady uptake under harmonized ESPEN guidelines, yet fragmentation in reimbursement creates variable country growth. Germany emphasizes immune-enhancing blends, the United Kingdom invests in mental-performance nutrition, and Italy's high per-capita supplement spend fosters premium tube-feeding adoption. Spain, conversely, values palatability aligned with culinary culture, spurring R&D on flavor masking.
Asia-Pacific is the fastest-growing arena, projected at 6.19% CAGR through 2030 as China, India, and Southeast Asia modernize ICUs and embrace homecare. Synutra's pivot from infant formula to adult meal replacements in China illustrates category stretch. Joint ventures, such as Nestle-Dr. Reddy's in India, leverage local distribution for specialized products. South America and the Middle East & Africa remain emerging, with Brazil's USD 209 billion food-processing sector and GCC healthcare investments hinting at long-term opportunity.
List of Companies Covered in this Report:
Nestle S.A. / Abbott Laboratories / Danone / Fresenius / B. Braun / Otsuka / Meiji Holdings Co., Ltd. / Ajinomoto Co., Inc. / Kate Farms, Inc. / Real Food Blends LLC / Nutritional Medicinals LLC / Victus / Hormel Foods / Reckitt/Mead Johnson & Company LLC / DSM-Firmenich / Cambrooke Therapeutics Inc. / Yakult Honsha Co., Ltd. / EA Pharma Co., Ltd. / Baxter / Nestle Health Science (Vitaflo) /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Aging population & surge in chronic diseases
4.2.2 Shift from parenteral to enteral nutrition in acute-care settings
4.2.3 Rapid uptake of home-enteral pumps & accessories
4.2.4 Clean-label real-food formulas boosting patient adherence
4.2.5 E-prescription-linked AI tools enabling personalized macronutrient titration
4.3 Market Restraints
4.3.1 GI-related complications & aspiration risk perceptions
4.3.2 Fragmented reimbursement for disease-specific formulas
4.3.3 Concentrated supply chain for specialty amino-acid blends
4.3.4 High viscosity of plant-based blends causing pump occlusion issues
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Industry Rivalry
5 Market Size & Growth Forecasts
5.1 By Product Type (Value)
5.1.1 Standard Polymeric Formulas
5.1.2 High-Protein Polymeric Formulas
5.1.3 Peptide-Based / Semi-Elemental Formulas
5.1.4 Elemental (Amino-Acid) Formulas
5.1.5 Disease-Specific Formulas
5.1.5.1 Diabetes-Specific
5.1.5.2 Renal-Specific
5.1.5.3 Hepatic Support
5.1.5.4 Oncology / Immunonutrition
5.1.5.5 Pulmonary (COPD)
5.1.5.6 GI & Malabsorption (IBD, SBS)
5.1.6 Immune-Modulating / Synbiotic Formulas
5.1.7 Blenderized Real-Food Formulas
5.2 By Caloric Density (Value)
5.2.1 Low Energy (<1.0 kcal/ml)
5.2.2 Isocaloric (?1.0 kcal/ml)
5.2.3 Hypercaloric (1.2 - 1.5 kcal/ml)
5.2.4 Very-High Calorie (?2.0 kcal/ml)
5.3 By End-user (Value)
5.3.1 Hospitals & Acute-Care Centres
5.3.2 Long-Term Care Facilities
5.3.3 Home Enteral Nutrition (HEN)
5.3.4 Out-patient / Ambulatory Clinics
5.4 By Age Group (Value)
5.4.1 Neonates (0-28 days)
5.4.2 Pediatrics (1 month-17 yrs)
5.4.3 Adults (18-64 yrs)
5.4.4 Geriatrics (?65 yrs)
5.5 By Geography (Value)
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 India
5.5.3.3 Japan
5.5.3.4 South Korea
5.5.3.5 Australia
5.5.3.6 Rest of Asia-Pacific
5.5.4 South America
5.5.4.1 Brazil
5.5.4.2 Argentina
5.5.4.3 Rest of South America
5.5.5 Middle East and Africa
5.5.5.1 GCC
5.5.5.2 South Africa
5.5.5.3 Rest of Middle East and Africa
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, and Recent Developments)
6.3.1 Nestle S.A.
6.3.2 Abbott Laboratories
6.3.3 Danone S.A.
6.3.4 Fresenius SE & Co. KGaA
6.3.5 B. Braun SE
6.3.6 Otsuka Pharmaceutical Co., Ltd.
6.3.7 Meiji Holdings Co., Ltd.
6.3.8 Ajinomoto Co., Inc.
6.3.9 Kate Farms, Inc.
6.3.10 Real Food Blends LLC
6.3.11 Nutritional Medicinals LLC
6.3.12 Victus, Inc.
6.3.13 Hormel Foods Corporation
6.3.14 Reckitt/Mead Johnson & Company LLC
6.3.15 DSM-Firmenich
6.3.16 Cambrooke Therapeutics Inc.
6.3.17 Yakult Honsha Co., Ltd.
6.3.18 EA Pharma Co., Ltd.
6.3.19 Baxter International Inc.
6.3.20 Nestle Health Science (Vitaflo)
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security